These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23311370)

  • 41. Mechanistic Model for Cancer Growth and Response to Chemotherapy.
    Simbawa E
    Comput Math Methods Med; 2017; 2017():3676295. PubMed ID: 28928794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells?
    Zhang L; Dermawan KT; Jin ML; Xiong SD; Chu YW
    Med Hypotheses; 2008 Nov; 71(5):802-4. PubMed ID: 18691831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function.
    Engelhart M; Lebiedz D; Sager S
    Math Biosci; 2011 Jan; 229(1):123-34. PubMed ID: 21129386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modelling and simulation of chemotherapy of haematological and gynaecological cancers.
    Nani FK; Oğuztöreli MN
    IMA J Math Appl Med Biol; 1999 Mar; 16(1):39-91. PubMed ID: 10335600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimal intervention strategies for cyclic therapeutic methods.
    Vahedi G; Faryabi B; Chamberland JF; Datta A; Dougherty ER
    IEEE Trans Biomed Eng; 2009 Feb; 56(2):281-91. PubMed ID: 19272947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapy of vascularised tumours: role of vessel density and the effect of vascular "pruning".
    d'Onofrio A; Gandolfi A
    J Theor Biol; 2010 May; 264(2):253-65. PubMed ID: 20100496
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor growth instability and its implications for chemotherapy.
    Castorina P; Carcò D; Guiot C; Deisboeck TS
    Cancer Res; 2009 Nov; 69(21):8507-15. PubMed ID: 19861540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug stability and compatibility in oncology care.
    Williams DA
    J Infus Chemother; 1996; 6(4):195-202. PubMed ID: 9229315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Current problems in surgical oncology: 1. Theoretical models in oncology and their implications in surgical therapy].
    Vasilescu C
    Chirurgia (Bucur); 2011; 106(1):17-22. PubMed ID: 21523955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mathematical model for chemotherapeutic drug efficacy in arresting tumour growth based on the cancer stem cell hypothesis.
    Ganguly R; Puri IK
    Cell Prolif; 2007 Jun; 40(3):338-54. PubMed ID: 17531079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Observer-based techniques for the identification and analysis of avascular tumor growth.
    Cacace F; Cusimano V; Di Paola L; Germani A
    Math Biosci; 2011 Dec; 234(2):147-53. PubMed ID: 22023728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy.
    Saitta C; Musolino C; Marabello G; Martino D; Leonardi MS; Pollicino T; Altavilla G; Raimondo G
    Dig Liver Dis; 2013 Aug; 45(8):683-6. PubMed ID: 23490344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer log-kill revisited.
    Norton L
    Am Soc Clin Oncol Educ Book; 2014; ():3-7. PubMed ID: 24857052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimization of an in vitro chemotherapy to avoid resistant tumours.
    Carrère C
    J Theor Biol; 2017 Jan; 413():24-33. PubMed ID: 27864095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of mathematical modeling in protocol formulation in cancer chemotherapy.
    Coldman AJ; Goldie JH
    Cancer Treat Rep; 1985 Oct; 69(10):1041-8. PubMed ID: 2412691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimal control oriented to therapy for a free-boundary tumor growth model.
    Calzada MC; Fernández-Cara E; Marín M
    J Theor Biol; 2013 May; 325():1-11. PubMed ID: 23485361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A therapy inactivating the tumor angiogenic factors.
    Morales-Rodrigo C
    Math Biosci Eng; 2013 Feb; 10(1):185-98. PubMed ID: 23311368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A mathematical model of cancer treatment by radiotherapy.
    Liu Z; Yang C
    Comput Math Methods Med; 2014; 2014():172923. PubMed ID: 25478002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Principles of current cancer chemotherapy.
    Wiemann MC; Calabresi P
    Compr Ther; 1983 Mar; 9(3):46-52. PubMed ID: 6839689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modeling and optimization of combined cytostatic and cytotoxic cancer chemotherapy.
    Villasana M; Ochoa G; Aguilar S
    Artif Intell Med; 2010 Nov; 50(3):163-73. PubMed ID: 20620035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.